International immunopharmacology · 2026
Microglial DNA G-quadruplex accumulation is associated with altered autophagy-related responses and aggravated ischemic brain injury.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin Rijin, Wan JiaXin, Fan Mengyan, Ma Yiming, Chen Liang, Zhang XiaoWen, Zhang Jiamei, Liu Huixiang, Zhang Nan, Zhong Li, Zhang Jie, Guan Sheng, Li Jing
Аннотация
Ischemic stroke creates a hypoxic and nutrient-deprived microenvironment that rapidly activates microglia, a central driver of post-ischemic inflammation and a key determinant of secondary tissue damage and neurological recovery. G-quadruplex (G4) structures are non-canonical nucleic acid conformations that can reshape stress responses in diverse settings, yet whether microglial DNA G4 relates to ischemic pathology remains unknown. Here, using a transient middle cerebral artery occlusion (tMCAO) mouse model and an oxygen-glucose deprivation/reoxygenation (OGD/R) primary microglia model, we examined how DNA G4 dynamics relate to microglial stress responses and post-ischemic outcomes. We found that cerebral ischemia induced a dynamic accumulation of microglial DNA G4 signal, accompanied by transient changes in autophagy-related markers. Pharmacological stabilization of G4 with pyridostatin (Pds) was associated with increased mTOR phosphorylation under ischemic stress, increased inhibitory ULK1 phosphorylation, and alterations in autophagy-related proteins, including a reduced LC3-II/LC3-I ratio, p62 accumulation, and downregulation of Beclin-1. In parallel, Pds treatment was associated with increased overall cellular stress under ischemic conditions. Under the prophylactic in vivo paradigm, Pds-treated mice showed larger infarct burden and worse neurological deficits. Importantly, the mTOR inhibitor rapamycin partially reversed Pds-associated autophagy-related changes and partially improved tissue and functional outcomes, although it did not fully normalize the broader stress-associated alterations. Collectively, our findings suggest that a pre-existing G4-stabilized state is associated with altered mTOR-ULK1/autophagy-related responses and aggravated ischemic outcomes, highlighting the G4-mTOR-autophagy-related axis as a potential contributor to post-ischemic microglial stress responses.